Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind Trial Evaluating the Safety and Efficacy of a 21-day Course of Albendazole 400mg/Day in Subjects With High Loa Loa Microfilaremia

NCT06613997 is registered in ClinicalTrials.gov with Programme National de Lutte contre l'Onchocercose, Republic of the Congo as lead sponsor.

NCT NCT06613997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06613997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind Trial Evaluating the Safety and Efficacy of a 21-day Course of Albendazole 400mg/Day in Subjects With High Loa Loa Microfilaremia
Lead sponsor
Programme National de Lutte contre l'Onchocercose, Republic of the Congo
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 15, 2025
Completion date
December 31, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

loiasis, loiasis with positive blood microfilaremia